Label-Free Impedimetric Aptasensor with Antifouling Surface Chemistry: a Prostate Specific Antigen Case Study

We here report the development of an aptamer based biosensor for the investigation of prostate specific antigen (PSA), a biomarker found in blood for prostate cancer (PCa), using electrochemical impedance spectroscopy (EIS). The study concentrates on a clinical application where a specific and sensitive label-free detection could be performed in real blood samples using EIS. Two types of PSA aptasensor were fabricated by immobilizing (i) a self-assembled monolayer comprising of 6-mercaptohexanol (MCH) and thiolated-DNA aptamer and (ii) 11-mercaptoundecanoic acid for covalent immobilization of amine terminated DNA aptamers and sulfo-betaine terminated thiol as an antifouling agent on a polycrystalline gold surface. Upon incubation of PSA with the DNA aptamer-based biosensor a decrease of charge transfer resistance (Rct) was observed due to the partial screening of the DNA aptamer charge by PSA. Thiol terminated sulfo-betaine based sensors can detect PSA levels lower than 1 ng/ml. Validation of the aptasensor is provided by surface plasmon resonance measurements. Sulfo-betaine moiety also prevents any significant non-specific binding of the control protein human serum albumin (HSA) as compared to high non-specific binding with MCH-based sensors. A debate is presented on the effect of the measurement buffer on the values and the direction of Rct changes on the aptasensors and the need to cautiously select suitable measurement conditions in order to obtain reliable results. This is the first report to date where a DNA aptamer-based biosensor was developed using thiol-terminated sulfo-betaine, which is a simple surface chemistry for the development of promising, cost-effective, label-free and sensitive electrochemical detection platforms for a range of analytes.

[1]  Michael Famulok,et al.  Label-free impedimetric aptasensor for lysozyme detection based on carbon nanotube-modified screen-printed electrodes. , 2012, Analytical biochemistry.

[2]  Julio Raba,et al.  Integrated microfluidic systems with an immunosensor modified with carbon nanotubes for detection of prostate specific antigen (PSA) in human serum samples. , 2008, Biosensors & bioelectronics.

[3]  F. Ivanauskas,et al.  Electrochemical impedance spectroscopy of tethered bilayer membranes. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[4]  Pedro Estrela,et al.  Optimization of label-free DNA detection with electrochemical impedance spectroscopy using PNA probes. , 2008, Biosensors & bioelectronics.

[5]  Ming Zhou,et al.  Solid-state probe based electrochemical aptasensor for cocaine: a potentially convenient, sensitive, repeatable, and integrated sensing platform for drugs. , 2010, Analytical chemistry.

[6]  Jian-hui Jiang,et al.  An aptazyme-based electrochemical biosensor for the detection of adenosine. , 2010, Analytica chimica acta.

[7]  Y. Perera,et al.  Development and validation of a quantitative ELISA for the measurement of PSA concentration. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[8]  P. Conroy,et al.  Aberrant PSA glycosylation—a sweet predictor of prostate cancer , 2013, Nature Reviews Urology.

[9]  K. Abe,et al.  Development of ultra-high sensitivity bioluminescent enzyme immunoassay for prostate-specific antigen (PSA) using firefly luciferase. , 2001, Luminescence : the journal of biological and chemical luminescence.

[10]  J. Kang,et al.  Novel electrical detection of label-free disease marker proteins using piezoresistive self-sensing micro-cantilevers. , 2005, Biosensors & bioelectronics.

[11]  E. Wang,et al.  PVP-coated graphene oxide for selective determination of ochratoxin A via quenching fluorescence of free aptamer. , 2011, Biosensors & bioelectronics.

[12]  M. Pumera,et al.  Impedimetric thrombin aptasensor based on chemically modified graphenes. , 2012, Nanoscale.

[13]  Chunhai Fan,et al.  Aptamer-based biosensors , 2008 .

[14]  G. Whitesides,et al.  Self-assembled monolayers of thiolates on metals as a form of nanotechnology. , 2005, Chemical reviews.

[15]  Yi Lu,et al.  Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. , 2010, Advanced drug delivery reviews.

[16]  Paul Leonard,et al.  Biosensor developments: application to prostate-specific antigen detection. , 2007, Trends in biotechnology.

[17]  B. Roling,et al.  Slow and fast capacitive process taking place at the ionic liquid/electrode interface. , 2012, Faraday discussions.

[18]  María Pedrero,et al.  Characterization of alkanethiol-self-assembled monolayers-modified gold electrodes by electrochemical impedance spectroscopy , 2006 .

[19]  X. Qu,et al.  A graphene functionalized electrochemical aptasensor for selective label-free detection of cancer cells. , 2011, Biomaterials.

[20]  D. Patel,et al.  Adaptive recognition by nucleic acid aptamers. , 2000, Science.

[21]  Guoming Xie,et al.  Detection of the human prostate-specific antigen using an aptasensor with gold nanoparticles encapsulated by graphitized mesoporous carbon , 2012, Microchimica Acta.

[22]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[23]  Jan Tkac,et al.  Ultrasensitive impedimetric lectin biosensors with efficient antifouling properties applied in glycoprofiling of human serum samples. , 2013, Analytical chemistry.

[24]  Z. Chen,et al.  An aptamer based resonance light scattering assay of prostate specific antigen. , 2012, Biosensors & bioelectronics.

[25]  P. R. Bueno,et al.  Comparing label free electrochemical impedimetric and capacitive biosensing architectures. , 2014, Biosensors & bioelectronics.

[26]  Chunyang Lei,et al.  Impedimetric aptasensor with femtomolar sensitivity based on the enlargement of surface-charged gold nanoparticles. , 2009, Analytical chemistry.

[27]  Koichi Abe,et al.  Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing. , 2010, Biosensors & bioelectronics.

[28]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[29]  Joseph Wang,et al.  Aptamer biosensor for label-free impedance spectroscopy detection of proteins based on recognition-induced switching of the surface charge. , 2005, Chemical communications.

[30]  Ying Zhuo,et al.  Simultaneous electrochemical detection of multiple analytes based on dual signal amplification of single-walled carbon nanotubes and multi-labeled graphene sheets. , 2012, Biomaterials.

[31]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[32]  E. Tamiya,et al.  Label-free immunosensor for prostate-specific antigen based on single-walled carbon nanotube array-modified microelectrodes. , 2007, Biosensors & bioelectronics.

[33]  Chifang Peng,et al.  Fabricated aptamer-based electrochemical "signal-off" sensor of ochratoxin A. , 2010, Biosensors & bioelectronics.

[34]  Ciara K O'Sullivan,et al.  Reusable impedimetric aptasensor. , 2005, Analytical chemistry.

[35]  Bingling Li,et al.  Amplified electrochemical aptasensor taking AuNPs based sandwich sensing platform as a model. , 2008, Biosensors & bioelectronics.

[36]  H. Woo,et al.  Current Status of Biomarkers for Prostate Cancer , 2013, International journal of molecular sciences.

[37]  Ilaria Palchetti,et al.  Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects. , 2012, Angewandte Chemie.

[38]  Pedro Estrela,et al.  Optimization of DNA immobilization on gold electrodes for label-free detection by electrochemical impedance spectroscopy. , 2008, Biosensors & bioelectronics.

[39]  J. Weinstein,et al.  Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.

[40]  Joseph Wang,et al.  Electrochemical Aptasensors – Recent Achievements and Perspectives , 2009 .

[41]  Deborah Schrag,et al.  Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. , 2005, Journal of the National Cancer Institute.